ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis

CONCLUSION: In pregnancies at high-risk of preterm preeclampsia identified by screening at 11-13 weeks' gestation, very high-risk results (estimated risk ≥1 in 50), compared to estimated risk of 1 in 51 to 1 in 100, chronic hypertension, compared to no chronic hypertension, and low PlGF concentration <0.712 MoM, compared to PlGF ≥0.712 MoM, are associated with the development of preterm preeclampsia despite aspirin prophylaxis. This article is protected by copyright. All rights reserved.PMID:33998099 | DOI:10.1002/uog.23668
Source: The Ultrasound Review of Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research